Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression
1999

Matrix Metalloproteinases and Melanoma Progression

Sample size: 8 publication Evidence: moderate

Author Information

Author(s): Hofmann U B, Westphal J R, Waas E T, Zendman A J W, Cornelissen I M H A, Ruiter D J, Muijen G N P van

Primary Institution: University Hospital, Nijmegen, The Netherlands

Hypothesis

Increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression.

Conclusion

The study found that only the expression of activated MMP-2 is associated with increased malignancy in melanoma.

Supporting Evidence

  • MMP-1 mRNA was detectable in all cell lines, but protein expression was too low to be detected.
  • MMP-2 mRNA and protein were present in all cell lines, with the highest levels in the most metastatic lines.
  • MMP-3 was expressed in some cell lines, but protein was only found in the most metastatic ones.
  • No MMP-9 was expressed in any melanoma cell lines.
  • TIMP-1 and TIMP-2 were present in all cell lines, but their expression did not correlate with metastatic capacity.

Takeaway

This study looked at how certain proteins are related to melanoma growth, and found that one protein, MMP-2, is really important for how bad the melanoma can get.

Methodology

The study used in vitro and in vivo models to analyze the expression of various matrix metalloproteinases and their inhibitors in melanoma cell lines and xenografts.

Digital Object Identifier (DOI)

10.1038/sj.bjc.6690763

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication